IQVIA Launches FluSTAR Mobile App to Help Consumers Manage Their Health During Flu and Cold Season
February 03 2020 - 8:00AM
Business Wire
Direct access for consumers to track the spread
of the flu and colds in the U.S.
IQVIA™ (NYSE: IQV) today announced the launch of the FluSTAR
mobile application to help consumers understand and track flu and
cold severity this winter. IQVIA’s FluStar app uses near real-time
updates complied at www.FluSTAR.com, for current illness
information for every ZIP code in the country, accessible from any
mobile device.
“The new FluSTAR app is a perfect example of the value of human
data science by enabling individuals to better manage their health
with quick and easy access to flu and cough-and-cold data when they
need it,” said Rob Kotchie, president real world solutions, IQVIA.
“Powered by the IQVIA CORE™, unparalleled data and advanced
analytics, FluSTAR puts the most up-to-date information on the
spread of the flu into the hands of healthcare professionals and
patients during each influenza season.”
FluSTAR data are gathered using non-identified patient
information through several surveillance methods, including rapid
assays, laboratory confirmation, and clinical diagnosis records.
This allows a regional and national picture of influenza activity
to be generated.
The FluSTAR app provides a combined index based on all relevant
conditions; flu, fever, cough, and strep. The map also provides
breakouts for each condition on the national and local level and is
updated regularly with season progress. The FluSTAR symptom tracker
also collects user feedback on the state of symptoms to further
understand and track seasonal suffering’s impact.
To download FluSTAR, search “FluSTAR Flu Tracking” in the app
store for your Android, Apple or Windows mobile device.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions and contract research services to
the life sciences industry. Formed through the merger of IMS Health
and Quintiles, IQVIA applies human data science — leveraging the
analytic rigor and clarity of data science to the ever-expanding
scope of human science — to enable companies to reimagine and
develop new approaches to clinical development and
commercialization, speed innovation and accelerate improvements in
healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers
unique and actionable insights at the intersection of large-scale
analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With approximately
65,000 employees, IQVIA conducts operations in more than 100
countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
Click here to subscribe to Mobile Alerts for IQVIA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200203005406/en/
Tor Constantino, IQVIA Media Relations
(tor.constantino@iqvia.com) +1.484.567.6732
Andrew Markwick, IQVIA Investor Relations
(andrew.markwick@iqvia.com) +1.973.257.7144
IQVIA (NYSE:IQV)
Historical Stock Chart
From Mar 2024 to Apr 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Apr 2023 to Apr 2024